Get the Stockscreener App
14.53
3.80%
-0.4639
Tourmaline Bio Inc stock is traded at $14.53, with a volume of 137.31K.
It is down -3.80% in the last 24 hours and down -28.58% over the past month.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
See More
Previous Close:
$14.99
Open:
$14.97
24h Volume:
137.31K
Relative Volume:
0.62
Market Cap:
$384.38M
Revenue:
-
Net Income/Loss:
$11.77M
P/E Ratio:
25.11
EPS:
0.5785
Net Cash Flow:
$-19.23M
1W Performance:
-10.21%
1M Performance:
-28.58%
6M Performance:
+5.26%
1Y Performance:
-59.06%
1-Day Range:
$14.15
$15.01
1-Week Range:
$14.15
$16.60
52-Week Range:
$12.12
$48.31
Tourmaline Bio Inc Stock (TRML) Company Profile
Name
Tourmaline Bio Inc
Sector
Industry
Phone
646-481-9832
Address
27 WEST 24TH STREET, NEW YORK
Compare TRML with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
14.50 | 384.38M | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.55 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
717.55 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
653.40 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.24 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.86 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Nov-11-24 | Reiterated | H.C. Wainwright | Buy |
| Dec-15-23 | Initiated | Jefferies | Buy |
| Dec-04-23 | Resumed | H.C. Wainwright | Buy |
| Nov-17-23 | Initiated | Truist | Buy |
| Oct-31-23 | Initiated | Guggenheim | Buy |
| Oct-25-23 | Initiated | Piper Sandler | Overweight |
| Oct-20-22 | Initiated | H.C. Wainwright | Buy |
| Jul-05-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
View All
Tourmaline Bio Inc Stock (TRML) Latest News
Tourmaline Bio Inc (TRML) Stock Showcases -13.66% 20-Day Moving Average - The News Heater
TRML’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Solventum Corp (SOLV) Shares Down Despite Recent Market Volatility - The News Heater
Jennison Associates LLC Sells 306,173 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat
Tourmaline Bio Inc (TRML) Becoming More Attractive for Investors - Knox Daily
In the Green: JBDI Holdings Ltd (JBDI) Closes at 0.65, Up/Down 11.02 from Previous Day - The Dwinnex
Closing Bell Recap: E.W. Scripps Co (SSP) Ends at 1.88, Reflecting a 6.82 Upturn - The Dwinnex
Post-Trade Analysis: Celldex Therapeutics Inc (CLDX) Slides -2.11, Closing at 23.15 - The Dwinnex
Market Insights: Avidity Biosciences Inc (RNA)’s Notable Gain of 4.32, Closing at 33.34 - The Dwinnex
Daily Market Movement: Tourmaline Bio Inc (TRML) Sees a 6.37 Increase, Closing at 16.53 - The Dwinnex
Keeping an Eye on Entegris Inc (ENTG) After Insider Trading Activity - Knox Daily
Potential Price Increase for Monster Beverage Corp (MNST) After Recent Insider Activity - Knox Daily
Recent Insider Activity Suggests Potential Gains for Vita Coco Company Inc (COCO) - Knox Daily
Jefferies Upgrades Relay Therapeutics Inc (RLAY) to a Buy from a Hold - Knox Daily
Short Interest in Tourmaline Bio, Inc. (NASDAQ:TRML) Rises By 26.8% - MarketBeat
We Tested Over 25 Curling Irons. These 13 Are the Best - MarieClaire.com
JPMorgan Chase & Co. Acquires 2,100 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Graves Ophthalmopathy Market to Expand Significantly by 2034, States DelveInsight Report | Novartis, AdvanceCor, Apitope, Worg Pharma, AV7 Limited - The Globe and Mail
Graves Ophthalmopathy Market to Expand Significantly by 2034, - openPR
Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference - Marketscreener.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Graves' Disease Market Size in the 7MM was ~USD 4,400 million - openPR
Cantor Fitzgerald Estimates Tourmaline Bio FY2025 Earnings - Defense World
Brokers Issue Forecasts for Tourmaline Bio FY2025 Earnings - MarketBeat
Barclays PLC Purchases Shares of 73,897 Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG) - Defense World
Barclays PLC Increases Position in Bit Digital, Inc. (NASDAQ:BTBT) - Defense World
Barclays PLC Has $830,000 Stake in NerdWallet, Inc. (NASDAQ:NRDS) - Defense World
Barclays PLC Purchases 190,520 Shares of Clean Energy Fuels Corp. (NASDAQ:CLNE) - Defense World
Barclays PLC Raises Holdings in First Bank (NASDAQ:FRBA) - Defense World
Barclays PLC Has $843,000 Holdings in Cantaloupe, Inc. (NASDAQ:CTLP) - Defense World
Barclays PLC Has $819,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Barclays PLC Has $819,000 Stake in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat
Tourmaline Bio Appoints Dr. Paul M. Ridker To Cardiovascular Scientific Advisory Board - citybiz
Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker - The Manila Times
Franklin Resources Inc. Makes New $339,000 Investment in ADT Inc. (NYSE:ADT) - Defense World
Vital Energy, Inc. (NYSE:VTLE) Stock Position Lifted by Franklin Resources Inc. - Defense World
JPMorgan Chase & Co. Buys 34,072 Shares of Sun Life Financial Inc. (NYSE:SLF) - Defense World
Climb Global Solutions, Inc. (NASDAQ:CLMB) Stock Holdings Lifted by Barclays PLC - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Position Lifted by Geode Capital Management LLC - Defense World
EDP – Energias de Portugal (OTCMKTS:EDPFY) Stock Price Crosses Below 200 Day Moving Average – Time to Sell? - Defense World
Barclays PLC Makes New Investment in Concentra Group Holdings Parent, Inc. (NYSE:CON) - Defense World
PBF Energy Inc. (NYSE:PBF) Shares Sold by Principal Financial Group Inc. - Defense World
Barclays PLC Has $810,000 Stock Holdings in ACCO Brands Co. (NYSE:ACCO) - Defense World
Geode Capital Management LLC Trims Stock Position in Playtika Holding Corp. (NASDAQ:PLTK) - Defense World
Geode Capital Management LLC Purchases 29,005 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat
Barclays PLC Acquires 4,125 Shares of NETGEAR, Inc. (NASDAQ:NTGR) - Defense World
StockNews.com Begins Coverage on Golden Minerals (NYSE:AUMN) - Defense World
Head to Head Review: VectivBio (NASDAQ:VECT) versus Tourmaline Bio (NASDAQ:TRML) - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Tourmaline Bio Inc Stock (TRML) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tourmaline Bio Inc Stock (TRML) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kulkarni Sandeep Chidambar | CEO |
Aug 16 '24 |
Buy |
13.79 |
5,221 |
71,998 |
5,221 |
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):